Technology News and Research

RSS

WellDoc DiabetesManager solution integrated with leading EHR system

WellDoc®, a healthcare company that develops technology solutions to improve chronic disease management outcomes and reduce healthcare costs, today announced the first integration of a clinically tested mHealth coaching platform with a leading electronic health records (EHR) system. The integration of the WellDoc DiabetesManager® solution into an EHR will streamline and enhance patient care by combining a best-in-class patient coaching platform and clinical decision support with the workflow efficiency of an EHR system.

13 Dec 2010

SunTech Medical, ADC launch ADView spot-check device

SunTech Medical and American Diagnostic Corporation announced today the launch of the ADView spot-check device. The ADView is a completely modular spot-check device capable of measuring blood pressure, temperature, and pulse oximetry in multiple clinical settings.

13 Dec 2010

Cedarlane to distribute TGR's new ELISA-One technology assay reagents in Canada and the US

TGR BioSciences, a leading global provider of advanced cell based assay technologies in the fields of cancer, kinase and GPCR research, is extremely pleased to announce a distribution partnership with Cedarlane Laboratories of Burlington, ON, Canada, a leading supplier of Life Science research reagents in North America.

13 Dec 2010

iTech Medical receives Health Canada approval for Muscle Pattern Recognition System

iTech Medical, Inc., a medical information technology company, announced today that it has received Health Canada approval for the Company's Muscle Pattern Recognition (MPR) System, a non-invasive clinical assessment tool being developed to assist in the diagnosis and treatment of back and neck pain, one of the most common chronic conditions in Canada.

13 Dec 2010

NinePoint enters IP licensing agreement with Massachusetts General Hospital

NinePoint Medical, Inc., an emerging leader in the development of in vivo pathology medical devices, today announced it has entered into an intellectual property (IP) licensing agreement with Massachusetts General Hospital (MGH). Under the agreement, NinePoint has certain exclusive rights in multiple fields to 188 patents and patent applications owned by MGH.

13 Dec 2010

Yissum introduces novel DNA profiling method for investigating complex crime scenes

Forensic DNA science has advanced significantly in the latest decade, and constitutes today the mainstay of forensic science. All serious crime scenes are routinely inspected for DNA evidence and many cases are solved by matching the DNA in the crime scene to that of a suspect. But often a crime scene will contain complex DNA mixtures (usually more than two individuals), and the detection of a particular DNA profile in such mixtures is challenging.

13 Dec 2010

Silicon Biosystems' newly formed subsidiary to commercialize DEPArray technology platform

Silicon Biosystems, S.p.A., a provider of specialized molecular and cell biology technology, today announced that it has formed a U.S. subsidiary operation, Silicon Biosystems, Inc., to be headquartered in San Diego, California. The newly formed business will focus on commercial operations and the development of the North American research and clinical diagnostics markets for the company's DEPArray™ technology platform.

13 Dec 2010

Scientists create functioning human intestinal tissue from pluripotent stem cells

For the first time, scientists have created functioning human intestinal tissue in the laboratory from pluripotent stem cells.

13 Dec 2010

OraSure commences enrollment in final study for FDA approval of OraQuick Rapid HIV-1/2 OTC test

OraSure Technologies, Inc., the market leader in oral fluid diagnostics, announced today that it has enrolled the first subject in its final phase of clinical studies for United States Food and Drug Administration ("FDA") approval of the Company's OraQuick® Rapid HIV-1/2 test for sale in the U.S. consumer or over-the-counter ("OTC") market.

13 Dec 2010

First-ever Prophylactic Cancer Vaccine Conference to be held in Tempe, Arizona

World-leading scientists, ethicists, policymakers, and cancer patient advocates will gather at Arizona State University for the first-ever Prophylactic Cancer Vaccine Conference in Tempe, Ariz., March 16-18, 2011. The conference will be a premier forum to discuss the latest developments in a radical new approach to battling cancer: the development of cancer vaccines aimed at protecting healthy individuals from the disease.

13 Dec 2010

New DNA-based testing technology for tuberculosis treatment

The driving force behind the rapid tuberculosis test that received World Health Organization endorsement this week is Dr. David Alland, chief of the Division of Infectious Disease at UMDNJ-New Jersey Medical School.

13 Dec 2010

Small amounts of mobility can reduce hospital stay for elderly patients

"You'll be back on your feet in no time" is a phrase familiar to anyone who's ever had to spend time in a hospital. Now, a new study has shown that hospitalized elderly patients who literally "get back on their feet" by taking even short walks around a hospital unit tend to leave the hospital sooner than their more sedentary peers.

13 Dec 2010

New initiative launched to fight cystic fibrosis

The University of British Columbia, in partnership with the Canadian Cystic Fibrosis Foundation (CCFF) and the Centre for Drug Research and Development (CDRD), today launches the Cystic Fibrosis Technology Initiative (CFTI) to advance Canadian technologies that will help combat cystic fibrosis (CF).

13 Dec 2010

Research programs embody the promise of anti-aging medicine.

Sometimes the value of research lies as much in exposing false remedies as in discovering true breakthroughs. Scientists at the country's first school of gerontology and in laboratories around the University of Southern California do both, mindful of their responsibility to a society focused on healthful aging.

13 Dec 2010

Prostate cancer study identifies 295 genes associated with clinical recurrence following radical prostatectomy

Genomic Health, Inc. today announced the first results of a large prostate cancer study that identified 295 genes strongly associated with clinical recurrence following radical prostatectomy. Top-line findings from this study, which applied the same RT-PCR technology used in Genomic Health's Oncotype DX® breast and colon cancer tests, will be presented today at the Society for Urologic Oncology (SUO) annual meeting.

13 Dec 2010

New York City surgeon performs first revision rhinoplasty cases with FDA approved PDS Plate

Today Dr. Steven Pearlman, prominent facial plastic and reconstructive surgeon based in New York City, will be performing one of the first revision rhinoplasty cases with the newly FDA approved PDS Plate. This revolutionary procedure will mark a giant leap in the world of cosmetic and reconstructive surgery.

13 Dec 2010

Stem cell therapy can reduce risk of acute leukemia in affected individuals

Some adults and children with acute leukemia could benefit from certain transplants of blood stem cells, but the benefits are not equal across all cases of leukemia, according to a new review of 15 studies.

13 Dec 2010

Complete Genomics announces CNV and SV results as part of complete human genome sequencing service

Complete Genomics Inc. announced today that its customers will now receive copy number variation (CNV) and structural variation (SV) results as part of the CGA™ Service. This new enhancement includes additional types of variation data including quantitative, large-scale copy number measurements and larger inter- and intrachromosomal rearrangements.

10 Dec 2010

Tomophase receives FDA 510(k) clearance to market Optical Coherence Tomography Imaging System

Tomophase Corporation, developer of the non-invasive Optical Coherence Tomography Imaging System (OCTIS™) and other devices, announced today that it has received FDA 510(k) clearance to market OCTIS.

10 Dec 2010

Pisgah's technology imparts abuse deterrence to commonly abused prescription drugs

Pisgah Labs announced today the findings from a proof of concept study confirming Pisgah's technology imparts abuse deterrence to commonly abused prescription drugs, particularly narcotics. The controlled study, conducted in dogs, was performed with the un-formulated active ingredient, hydrocodone, as modified according to a host of patent applications filed by Pisgah Labs with the United States Patent and Trademark Office (http://www.uspto.gov).

10 Dec 2010

Technology News and Research

WellDoc DiabetesManager solution integrated with leading EHR system

SunTech Medical, ADC launch ADView spot-check device

Cedarlane to distribute TGR's new ELISA-One technology assay reagents in Canada and the US

iTech Medical receives Health Canada approval for Muscle Pattern Recognition System

NinePoint enters IP licensing agreement with Massachusetts General Hospital

Yissum introduces novel DNA profiling method for investigating complex crime scenes

Silicon Biosystems' newly formed subsidiary to commercialize DEPArray technology platform

Scientists create functioning human intestinal tissue from pluripotent stem cells

OraSure commences enrollment in final study for FDA approval of OraQuick Rapid HIV-1/2 OTC test

First-ever Prophylactic Cancer Vaccine Conference to be held in Tempe, Arizona

New DNA-based testing technology for tuberculosis treatment

Small amounts of mobility can reduce hospital stay for elderly patients

New initiative launched to fight cystic fibrosis

Research programs embody the promise of anti-aging medicine.

Prostate cancer study identifies 295 genes associated with clinical recurrence following radical prostatectomy

New York City surgeon performs first revision rhinoplasty cases with FDA approved PDS Plate

Stem cell therapy can reduce risk of acute leukemia in affected individuals

Complete Genomics announces CNV and SV results as part of complete human genome sequencing service

Tomophase receives FDA 510(k) clearance to market Optical Coherence Tomography Imaging System

Pisgah's technology imparts abuse deterrence to commonly abused prescription drugs

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News